Research on Stem Cell-derived Exosomes in Regenerative Medicine

Mesenchymal stem cells widely distribute in human tissues, with self-renewal and multi-directional differentiation potential, and have important applications in regenerative medicine. However, there are still some limitations in the clinical application of stem cells, such as tumorigenic risk, ethics, and immune rejection, which seriously hinder the transformation of stem cell therapy. Therefore, it is an urgent need to improve stem cell therapy technology and avoid all kinds of risks and problems. It has been found that the tissue regeneration function of stem cells mainly stems from the effect of paracrine. Exosomes play an important role in regulating the function based on the effect of paracrine from stem cells. Exosomes are nanoscale liposome vesicles secreted by cells and serve as intercellular messengers that transport important cellular inclusion, thereby regulating the specific functions of the target cell. Previous studies have shown that stem cell-derived exosomes have the function of promoting the repair and regeneration of damaged tissues similar to stem cells. Stem cell-derived exosomes can promote damaged tissue repair and regeneration while avoiding the risk of direct stem cell transplantation, and have the advantage of easy storage and transportation, showing broad clinical application prospects.

We welcome original research articles, reviews, mini-reviews, and opinion pieces related to the following topics

1. The exploration and research of stem cell-derived exosomes in the field of regenerative medicine such as tissue/organ damage repair, tissue regeneration, and functional recovery;

2. Research on the function of bioactive substances contained in stem cell-derived exosomes and application in the field of regenerative medicine;

3. Basic research on stem cell-derived exosomes promoting tissue repair by activating related signal pathways;

4. Basic research on stem cell-derived exosomes regulating immune response during the process of tissue repair by activating related signal pathways;

5. Research on the application of stem cell-derived exosomes as nanocarriers in the field of regenerative medicine;

6. Research on the application of combined therapy of stem cell-derived exosomes and biomaterials;

7. Research on the potential target cells/tissues in tissue repair connected with stem cell-derived exosomes;

8. New technology for purification and mass production of stem cell-derived exosomes;

9. New technology for modification of stem cell-derived exosomes;

10. New strategies for the design of artificial stem cell-derived exosomes;

11. Research on developing novel disease-on-a-chip models for high throughput screening of the therapeutic effects of stem cell-derived exosomes;

12. Research on revealing the regulatory effect of stem cell-derived exosomes on the mechanotransduction of various target cells in tissue engineering and immunotherapy.